Double-blind, placebo-controlled trial of toremifene for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia.

被引：0

作者：

Price, D

Stein, B

Goluboff, E

Sieber, P

Bostwick, D

Barnette, G

Boger, R

Steiner, MS

机构：

[1] Reg Urol LLC, Shreveport, LA USA

[2] Univ Urol Assoc Inc, Providence, RI USA

[3] Columbia Presbyterian Med Ctr, New York, NY USA

[4] Urol Assoc Lancaster, Lancaster, PA USA

[5] Bostwick Labs, Richmond, VA USA

[6] GTx Inc, Memphis, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：106S / 106S

页数：1

共 50 条

[1] Toremifene for the prevention of prostate cancer among 514 men with high-grade prostatic intraepithelial neoplasia (PIN): Results of a double-blind, placebo-controlled phase IIB trial
Price, D
Stein, B
Goluboff, E
Sieber, P
Bostwick, D
Barnette, KG
Steiner, MS
[J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 188 - 189
[2] Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: Results of a double-blind, placebo controlled, phase IIB clinical trial
Price, David
Stein, Barry
Sieber, Paul
Tutrone, Ronald
Bailen, James
Goluboff, Erik
Burzon, Daniel
Bostwick, David
Steiner, Mitchell
[J]. JOURNAL OF UROLOGY, 2006, 176 (03): : 965 - 970
[3] Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: Results of a double-blind, placebo controlled, phase IIB clinical trial - Editorial comment - Reply by authors
不详
[J]. JOURNAL OF UROLOGY, 2006, 176 (03): : 970 - 971
[4] miRNA expression profiles in high-grade prostatic intraepithelial neoplasia.
Eminaga, Okyaz
Woetzel, Fabian
Fries, Jochen
Neiss, Susanne
Heitmann, Michaela
Engelmann, Udo
Heidenreich, Axel
Warnecke-Eberz, Ute
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[5] Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia
Marshall, James R.
Sakr, Wael
Wood, David
Berry, Donna
Tangen, Catherine
Parker, Felicia
Thompson, Ian
Lippman, Scott M.
Lieberman, Ronald
Alberts, David
Jarrard, David
Coltman, Charles
Greenwald, Peter
Minasian, Lori
Crawford, E. David
[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (08) : 1479 - 1484
[6] High-grade Prostatic Intraepithelial Neoplasia of the Prostate: The Precursor Lesion of Prostate Cancer
Zynger, Debra L.
Yang, Ximing
[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2009, 2 (04): : 327 - 338
[7] High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction
Mitchell S. Steiner
[J]. World Journal of Urology, 2003, 21 : 15 - 20
[8] High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction
Steiner, MS
[J]. WORLD JOURNAL OF UROLOGY, 2003, 21 (01) : 15 - 20
[9] Utility of ERG in prostate cancer and high-grade prostatic intraepithelial neoplasia
Allina, D.
Andreeva, Y.
Zavalishina, L.
Moskvina, L.
Frank, G.
[J]. VIRCHOWS ARCHIV, 2015, 467 : S20 - S20
[10] Baseline characteristics validate the inclusion criteria of a phase III comparison of toremifene and placebo for the prevention of prostate cancer in men with isolated high grade prostatic intraepithelial neoplasia (HGPIN)
Taneja, S. S.
[J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 224 - 224

← 1 2 3 4 5 →